Updated October 21, 2026. This article explains a research review and offers an editorial checklist for evaluating claims about clinical AI. It does not provide medical advice.
A review published in npj Artificial Intelligence on March 5, 2026 examines how AI agents are being studied in healthcare. Its value is a map of applications and evaluation problems, rather than a single verdict that agents are ready to replace clinicians.
What the review actually covers
Zhao and colleagues discuss diagnosis support, clinical decisions, report generation, health management, and medical education. They describe agents as systems combining a language model with planning, memory, tools, and reflection. Their literature search covered Web of Science, PubMed, and arXiv, with attention to work through February 2025.
The authors call for broader evaluation: technical correctness alone is insufficient. Safety, patient experience, cost, oversight, and clinical usefulness also matter. They acknowledge that this fast-moving field and publication delays limit how complete any review can be.
How to read an impressive performance claim
Our editorial test is to separate three questions: what task was tested, what evidence supports the result, and what action a real system would be allowed to take. A strong answer to the first question does not automatically answer the other two.
For example, choosing an answer from a prepared set and proposing the next step for a patient are different responsibilities. Before treating a comparison as meaningful, ask whether both systems received the same information, faced the same time constraints, and were judged against the same reference standard.
Also ask what happens after an error. A draft that a clinician checks before saving has a different failure path from an instruction acted on without review. Describing that path is more useful than calling either system simply “autonomous.”
A practical evidence checklist
- Population: Who was included, and who was left out?
- Setting: Was this a simulation, a retrospective test, or prospective use in care?
- Comparator: What was the baseline, and was the comparison fair?
- Outcome: Did the study measure answer accuracy, workflow performance, or patient outcomes?
- Responsibility: Who reviews an output, can stop the system, and handles mistakes?
- Transfer: What evidence supports use at a different institution?
This checklist is our suggested way to interrogate a claim, not a validated clinical assessment instrument. A vendor or headline that cannot answer these questions has left essential information out.
Why governance belongs in the same conversation
The World Health Organization’s guidance on large multi-modal models considers their potential in healthcare, research, public health, and drug development. It also notes that broad general-purpose capability has not been established. That is a reason to ask for evidence for the exact proposed use.
For readers evaluating an AI announcement, the useful takeaway is to look for a defined task, a clear comparison, and accountable oversight. A research review can organize the questions; an individual deployment still needs its own answers.
Correction
An earlier version attributed specific study counts, diagnostic and clinician-override percentages, and deployment timelines to the review without adequate support. Those claims have been removed. The headline has also been revised to avoid describing this review as definitive.
Sources
- Zhao, L., Liu, S., Xin, T. et al. AI agent in healthcare: applications, evaluations, and future directions. npj Artificial Intelligence 2, 31 (2026).
- World Health Organization. Ethics and governance of artificial intelligence for health: Guidance on large multi-modal models.
